OSTEONECROSIS

This page is part of the PanCare PLAIN summaries about late effects and recommendations for long-term follow-up care for survivors of childhood, adolescent, and young adult cancer. Click here, for more information on the PLAIN summaries.
PLAIN version 3: 03/03/2025

This PLAIN summary is based on the PanCare Follow-Up guideline about “Osteonecrosis” [1], which is based on the consensus of different national guidelines.

Osteonecrosis

All the bones in our body make up our skeleton. We need our bones to stay upright, to help us move and to protect our organs. Each bone has a hard, calcified layer of bone on the outside. Underneath this hard layer is a softer, spongy bone.

Inside the bone are bone cells, which are responsible for keeping the bone healthy. They do this by constantly removing old layers of bone and producing new bone to take its place. For this process, bone cells need oxygen and nutrients from the bloodstream.

Sometimes problems can occur with the bones when they do not get enough blood and die. This is called osteonecrosis (avascular necrosis). Osteonecrosis can happen in any bone, but is most common in the end of long bones involved in a joint, especially the thigh and upper arm bones.

All the bones in our body make up our skeleton. We need our bones to stay upright, to help us move and to protect our organs. Each bone has a hard, calcified layer of bone on the outside. Underneath this hard layer is a softer, spongy bone.

Inside the bone are bone cells, which are responsible for keeping the bone healthy. They do this by constantly removing old layers of bone and producing new bone to take its place. For this process, bone cells need oxygen and nutrients from the bloodstream.

Sometimes problems can occur with the bones when they do not get enough blood and die. This is called osteonecrosis (avascular necrosis). Osteonecrosis can happen in any bone, but is most common in the end of long bones involved in a joint, especially the thigh and upper arm bones.

The bone
Created with
BioRender.com

Hover of the numbers in the figure for more information.

The bone
Created with
BioRender.com

Hover of the numbers in the figure for more information.

Am I at higher risk of osteonecrosis?

Anyone, including people who have never had cancer treatment, may develop osteonecrosis. However, there are some medical conditions and treatments that may increase the risk of having osteonecrosis. The problems that can occur depend on the type of cancer treatment received.

The following treatments can increase the risk of osteonecrosis:

You can find out if you had any of these medical conditions or treatments by looking at your treatment summary. If you do not have a treatment summary or if you have any questions, do contact your treating hospital.

If you experience osteonecrosis, it does not always mean that they are caused by your cancer treatment. Osteonecrosis may have other causes, such as injury of the bones or drinking too much alcohol

What are the symptoms and signs of osteonecrosis?

symptoms and signs

There are symptoms and signs that can tell you if you might have osteonecrosis. You might not have these symptoms and signs at the moment, but it is important to be aware of them in case they may develop in the future.

Symptoms and signs of osteonecrosis are:

  • Pain in a joint, especially during exercise, but sometimes also when resting
  • Joint stiffness
  • Reduced range of motion

If you recognise any of these symptoms or signs in yourself, please contact your general practitioner or follow-up care specialist. These symptoms and signs are often caused by something else.

I am at higher risk of osteonecrosis. What tests should I have and when?

If you are at higher risk of osteonecrosis, it is advised to:

  • Discuss your medical history and whether you experience(d) any symptoms and signs of osteonecrosis with your general practitioner or follow-up care specialist once at entry intolong-term follow-up (LTFU) and at least every 5 years after that.

What happens if I have low BMD?

If you have osteonecrosis, your general practitioner or follow-up care specialist will probably refer you to a specialist. Depending on the symptoms and/or signs you experience, you may be referred to an:

  • Orthopaedic surgeon (surgeon specialised in bones and joints)

The specialist may discuss different treatment options with you.

What else can I do?

Knowing that you may be at increased risk of osteonecrosis can be difficult. Talking to friends and family can be helpful as well as specialist counselling and/or contact with support groups, such as patient organisations. For more information on taking care of your mental health, please read: Mental health problems.

To lower your risk of osteonecrosis, it is very important to live a healthy lifestyle. In particular, it is important to exercise to strengthen your bones. It is advised to do exercises (such as cycling, tennis or doing housework) for at least 150 minutes a week. For adolescents, it is recommended to spend at least 60 minutes a day with moderate- to vigorous-intensity exercise (such as hiking, swimming or dancing). Taking care of your mental health may be beneficial; even small changes to your lifestyle can have a positive impact on both your physical and mental health. For more information on taking up a healthier lifestyle, please read: Health promotion.

The nutrients calcium and vitamin D are especially important to keep your bones strong. Calcium rich foods include dairy products, nuts, kale and bread. Fatty fish, margarine, halvarine and mushrooms are great sources of vitamin D. The body also produces its own vitamin D when exposed to sunlight. However, be aware that too much sun exposure can be harmful. If you cannot get enough of these nutrients through your diet, it might be necessary to take supplements with calcium and vitamin D. It is advised to consume at least 10 micrograms (µg) of vitamin D per day and at least 500 milligrams (mg) of calcium per day.

It is also important to consider fall prevention. This can involve making sure that your home is safe and has no fall hazards, having your vision regularly checked on and wearing appropriate footwear.

It is important that you are aware of the possibility of developing osteonecrosis and that you know the symptoms and signs. If you have any further questions or if the information in this brochure concerns you, please contact your general practitioner or follow-up care specialist.

Where can I find more information?

You may find more information about bone problems online. However, it is important to be aware that this information is not always up to date or accurate.

On this website, you can also find more information related to this topic:

Please note

This PLAIN summary is based on the PanCare Follow-Up guideline about “Osteonecrosis” [1], which is based on the consensus of different national guidelines.

While the PanCare PLAIN information group strives to provide accurate and complete information that is up-to-date as of the date of publication, you can check with your general practitioner or follow-up care specialist if this summary reflects the most up-to-date information available and whether it is relevant for you.

Please do not rely solely on this information. It is best to also seek the advice of a qualified medical practitioner if you have questions regarding a specific medical condition, disease, diagnosis or symptom.

No warranty or representation, expressed or implied, is made concerning the accuracy, reliability, completeness, relevance, or timeliness of this information. PanCare has produced the English version and PanCare is not responsible for the translated versions of this summary.

The PanCare materials are free to use for anyone aiming to inform about late effects and long-term survivorship care. However, no financial advantage may be achieved. All communication should reference PanCare and link to the PanCare website.

[1] van Kalsbeek, R. et al. (2021) European PANCAREFOLLOWUP recommendations for surveillance of late effects of childhood, adolescent, and Young Adult Cancer, European journal of cancer. Available at: https://www.ejcancer.com/article/S0959-8049(21)00368-3/fulltext